Ronald Blue Trust, Inc. Neogenomics Inc Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,125 shares of NEO stock, worth $12,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,125
Previous 4,421
74.55%
Holding current value
$12,240
Previous $72,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$214 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$155 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$71 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$67.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$67 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.37B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...